Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
D001545:Benserazide / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D001665:Binding Sites / Q000187:drug effects; D002230:Carbidopa / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D004347:Drug Interactions; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D007700:Kinetics; D007980:Levodopa / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D008111:Liver Function Tests; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D007980:Levodopa; D001545:Benserazide; D002262:Carboxy-Lyases; D002230:Carbidopa